Advancing research across heart, blood and kidney health
Through cardiovascular, metabolic and kidney research in clinic and lab environments, our researchers focus on the biology influencing disease. Our research efforts focus on improving diagnoses and identifying new pathways and treatments that improve the quality of life for patients with heart, blood and kidney diseases.
Learn more about who we are
Research News
New study reveals association between elevated plasma levels of the gut microbiome TMAO pathway and higher risk of AAA development and AAA adverse events.
Cleveland Clinic researchers have uncovered how anthracycline induces heart damage in humans and developed a proof-of-concept strategy to protect cancer patients’ hearts.
This team tested nearly 8,000 compounds to find one that reduces platelet activity through the olfactory receptors.